A widening of the definition of a gene therapy medicinal product (GTMP) is among the many changes proposed in draft legislation, which once finalized, will reform the EU pharmaceutical legislation.
As it stands, the draft text will see an “all-encompassing definition” introduced for GTMPs, said Christian Schneider, of the pharmaceutical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?